Coenzyme Q10 and its relation with oxidant and antioxidant system markers in patients with end-stage renal disease

Renal Failure

Volumn 33, Issue 7, 2011, Pages 677-681

  Gokbel, Hakki ^a   Atalay, Huseyin ^a   Okudan, Nilsel ^a   Solak, Yalcin ^a   Belviranli, Muaz ^a   Turk, Suleyman ^a  

^a SELCUK UNIVERSITY   (Turkey)

Author keywords

Antioxidant system; Chronic kidney disease; Coenzyme Q10; Hemodialysis; Malondialdehyde; Oxidative stress; Peritoneal dialysis

Indexed keywords

ANTIOXIDANT; MALONALDEHYDE; OXIDIZING AGENT; SUPEROXIDE DISMUTASE; UBIDECARENONE;

ADULT; AGED; ANTIOXIDANT ACTIVITY; ARTICLE; BLOOD LEVEL; CONTINUOUS AMBULATORY PERITONEAL DIALYSIS; HEMODIALYSIS PATIENT; HUMAN; KIDNEY FAILURE; MAJOR CLINICAL STUDY; OXIDATIVE STRESS; PRIORITY JOURNAL;

ANTIOXIDANTS; BIOLOGICAL MARKERS; COHORT STUDIES; CROSS-SECTIONAL STUDIES; HUMANS; KIDNEY FAILURE, CHRONIC; MIDDLE AGED; OXIDATIVE STRESS; PERITONEAL DIALYSIS; RENAL DIALYSIS; SUPEROXIDE DISMUTASE; UBIQUINONE;

EID: 79960823224     PISSN: 0886022X     EISSN: 15256049     Source Type: Journal    
DOI: 10.3109/0886022X.2011.589941     Document Type: Article

References (30)

1. Himmelfarb J, Hakim RM. Oxidative stress in uremia. Curr Opin Nephrol Hypertens. 2003;12(6):593-598. (Pubitemid 38186749)
2. Nguyen-Khoa T, Massy ZA, De Bandt JP, et al. Oxidative stress and hemodialysis: Role of inflammation and duration of dialysis treatment. Nephrol Dial Transplant. 2001;16(2):335-340. (Pubitemid 32123923)
3. Danielski M, Ikizler TA, McMonagle E, et al. Linkage of hypoalbuminemia, inflammation, and oxidative stress in patients receiving maintenance hemodialysis therapy. Am J Kidney Dis. 2003;42(2):286-294. (Pubitemid 36944436)
4. Widlansky ME, Gokce N, Keaney JF Jr, Vita JA. The clinical implications of endothelial dysfunction. J Am Coll Cardiol. 2003;42(7):1149-1160. (Pubitemid 37188333)
5. Altunoluk B, Soylemez H, Oguz F, Turkmen E, Fadillioglu E. An Angiotensin-converting enzyme inhibitor, zofenopril, prevents renal ischemia/reperfusion injury in rats. Ann Clin Lab Sci. 2006;36(3):326-332. (Pubitemid 44320428)
6. Karaman A, Turkmen E, Gursul C, Tas E, Fadillioglu E. Prevention of renal ischemia/reperfusion-induced injury in rats by leflunomide. Int J Urol. 2006;13(11):1434-1441. (Pubitemid 44657055)
7. Miyata T, van Ypersele de Strihou C, Kurokawa K, Baynes JW. Alterations in nonenzymatic biochemistry in uremia: Origin and significance of "carbonyl stress" in long-term uremic complications. Kidney Int. 1999;55(2):389-399. (Pubitemid 29082866)
8. Handelman GJ,Walter MF, Adhikarla R, et al. Elevated plasma F2-isoprostanes in patients on long-term hemodialysis. Kidney Int. 2001;59(5):1960-1966. (Pubitemid 32336813)
9. Canaud B, Cristol J, Morena M, Leray-Moragues H, Bosc J, Vaussenat F. Imbalance of oxidants and antioxidants in hemodialysis patients. Blood Purif. 1999;17(2-3):99-106. (Pubitemid 29403567)
10. Lippa S, Colacicco L, Calla C, Sagliaschi G, Angelitti AG. Coenzyme Q10 levels, plasma lipids and peroxidation extent in renal failure and in hemodialytic patients. Mol Aspects Med. 1994;15(Suppl. 15):s213-s219.
11. Lippa S, Colacicco L, Bondanini F, et al. Plasma levels of coenzyme Q(10), vitamin E and lipids in uremic patients on conservative therapy and hemodialysis treatment: Some possible biochemical and clinical implications. Clin Chim Acta. 2000;292(1-2):81-91. (Pubitemid 30109256)
12. Gazdikova K, Gvozdjakova A, Kucharska J, Spustova V, Braunova Z, Dzurik R. Oxidative stress and plasma concentrations of coenzyme Q10, alpha-tocopherol, and beta-carotene in patients with a mild to moderate decrease of kidney function. Nephron. 2001;88(3):285. (Pubitemid 32623498)
13. Wanner C, Bahner U, Mattern R, Lang D, Passlick-Deetjen J. Effect of dialysis flux and membrane material on dyslipidaemia and inflammation in hemodialysis patients. Nephrol Dial Transplant. 2004;19(10):2570-2575. (Pubitemid 39360106)
14. Bentinger M, Tekle M, Dallner G. Coenzyme Q-Biosynthesis and functions. Biochem Biophys Res Commun. 2010;396(1): 74-79.
15. Ernster L. Lipid Peroxidation in Biological Membranes: Mechanism and Implications. Active Oxygens, Lipid Peroxides, and Antioxidents. Boco Raton, FL: CRC Press; 1993.
16. Guan Z, SoderbergM, Sindelar P, Prusiner SB, Kristensson K, Dallner G. Lipid composition in scrapie-infected mouse brain: Prion infectin increases the levels of dolichyl phosphate and ubiquinone. J Neurochem. 1996;66(1):277-285. (Pubitemid 26010791)
17. Wasowicz W, Neve J, Peretz A. Optimized steps in fluorometric determination of thiobarbituric acid-reactive substances in serum: Importance of extraction pH and influence of sample preservation and storage. Clin Chem. 1993;39(12): 2522-2526. (Pubitemid 24008241)
18. Sun Y, Oberley LW, Li Y. A simple method for clinical assay of superoxide dismutase. Clin Chem. 1988;34(3):497-500.
19. Durak I, Yurtarslanl Z, Canbolat O, Akyol O. A methodological approach to superoxide dismutase (SOD) activity assay based on inhibition of nitroblue tetrazolium (NBT) reduction. Clin Chim Acta. 1993;214(1):103-104. (Pubitemid 23055374)
20. Koracevic D, Koracevic G, Djordjevic V, Andrejevic S, Cosic V. Method for the measurement of antioxidant activity in human fluids. J Clin Pathol. 2001;54(5):356-361. (Pubitemid 32458132)
21. Guo CH, Wang CL, Chen PC, Yang TC. Linkage of some trace elements, peripheral blood lymphocytes, inflammation, and oxidative stress in patients undergoing either hemodialysis or peritoneal dialysis. Perit Dial Int. 2010; in press.
22. Ozden M, Maral H, Akaydin D, Cetinalp P, Kalender B. Erythrocyte glutathione peroxidase activity, plasma malondialdehyde and erythrocyte glutathione levels in hemodialysis and CAPD patients. Clin Biochem. 2002;35(4): 269-273. (Pubitemid 34808731)
23. Mircescu G. Oxidative stress: An accomplice to uremic toxicity? J Ren Nutr. 2006;16(3):194-198. (Pubitemid 43975007)
24. Samouilidou EC, Grapsa EJ, Kakavas I, Lagouranis A, Agrogiannis B. Oxidative stress markers and C-reactive protein in end-stage renal failure patients on dialysis. Int Urol Nephrol. 2003;35(3):393-397. (Pubitemid 39127558)
25. Taskapan MC, Keskin L, Sahin I, et al. Relationship between insulin resistance and malondialdehyde levels in dialysis patients. Ren Fail. 2007;29(5):649-651. (Pubitemid 47123814)
26. Filiopoulos V, Hadjiyannakos D, Takouli L, Metaxaki P, Sideris V, Vlassopoulos D. Inflammation and oxidative stress in end-stage renal disease patients treated with hemodialysis or peritoneal dialysis. Int J Artif Organs. 2009;32(12):872-882.
27. Kayabasi H, Sit D, Atay AE, Yilmaz Z, Kadiroglu AK, Yilmaz ME. Parameters of oxidative stress and echocardiographic indexes in patients on dialysis therapy. Ren Fail. 2010;32(3):328-334.
28. Taskapan MC, Taskapan H, Sahin I, Keskin L, Atmaca H, Ozyalin F. Serum leptin, resistin, and lipid levels in patients with end stage renal failure with regard to dialysis modality. Ren Fail. 2007;29(2):147-154.
29. Giustarini D, Dalle-Donne I, Tsikas D, Rossi R. Oxidative stress and human diseases: Origin, link, measurement, mechanisms, and biomarkers. Crit Rev Clin Lab Sci. 2009;46(5- 6):241-281.
30. De Vecchi AF, Bamonti F, Novembrino C, et al. Free and total plasma malondialdehyde in chronic renal insufficiency and in dialysis patients. Nephrol Dial Transplant. 2009;24(8):2524-2529.